Any feedback?
Literature summary for 3.1.3.2 extracted from
- Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction (2008), Clin. Endocrinol. (Oxf.), 69, 189-196.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | serum TRACP5b is a good marker for serum bone resorption in predialysis chronic kidney disease patients, as it is not affected by renal dysfunction | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| serum | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| serum tartrate-resistant acid phosphatase | - |
Homo sapiens |
| TRACP5b | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
